March 6, 2018 / 11:22 PM / 5 months ago

BRIEF-U.S. FDA Approves First Tests To Screen For Tickborne Parasite In Whole Blood & Plasma

March 6 (Reuters) - U.S. Food and Drug Administration:

* U.S. FDA SAYS APPROVED THE IMUGEN BABESIA MICROTI ARRAYED FLUORESCENT IMMUNOASSAY FOR DETECTING ANTIBODIES TO BABESIA MICROTI IN HUMAN PLASMA SAMPLES

* U.S. FDA SAYS APPROVED THE IMUGEN BABESIA MICROTI NUCLEIC ACID TEST FOR DETECTING B. MICROTI DNA IN HUMAN WHOLE BLOOD SAMPLES

* U.S. FDA SAYS APPROVAL OF THE IMUGEN BABESIA MICROTI AFIA AND NAT TESTS WAS GRANTED TO OXFORD IMMUNOTEC INC Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below